INTRODUCTION
Thymus-derived or T-lymphocyte' function may be an important determinant in the host response to hepatitis infection (1) (2) (3) . The persistence of hepatitis-B surface antigen (HB.Ag) in the serum following an attack of hepatitis B is frequently associated with the development of chronic active and chronic persistent hepatitis (4) . Cell-mediated immunity in chronic carriers of hepatitis-B antigen and in patients with chronic active hepatitis (CAH) has been reported to be abnormal when assessed by in vitro assays such as phytohemagglutinin (PHA)-stimulated lymphocyte blast transformation and leukocyte migration inhibition (1) (2) (3) 5) . Thus, studies were performed to assess the role of T-lymphocyte function in patients with acute and chronic hepatitis and controls. Lymphocyte blastogenesis was measured by the incorporation of ['H]thymidine after stimulation with concanavalin A (Con A) and effector T-lymphocyte function was studied by both spontaneous and Con A-induced lymphocyte cytotoxicity. We also evaluated the importance of serum factors in the in vitro assessment of cellular immunity in these hepatitis patients. Finally, the in vivo effect of prednisone administration on lymphocyte function was investigated in vitro in patients with CAH because of the often observed clinical response of these patients to such therapy.
METHODS
Patients. 22 patients with acute and chronic hepatitis were studied. The clinical features of these patients at the time of study are shown in Table I . An additional nine healthy volunteers served as control subjects. All control subjects were found negative for HB.Ag and surface hepatitis-B antibody by hemagglutination and hemagglutination inhibition (6) . ' Abbreviations used in this paper: CAH, chronic active hepatitis; Con A, concanavalin A; HB.Ag, hepatitis-B surface antigen; PHA, phytohemagglutinin; T lymphocyte, thymus-derived lymphocyte.
The Journal of Clinical Investigation Volume 55 May 1975a921-929 Cytotoxicity studies. 2 ml of 1 X 106 lymphocytes/ml were added to 1 ml of 1 X 10' labeled Chang liver cells to yield a lymphocyte target cell ratio of 200 to 1. These suspensions were incubated on a rocker platform for 6 h at 37°C under a 95% air, 5% carbon dioxide atmosphere. At the end of the incubation period, the cell suspensions were transferred from 35 X 25-mm plastic petri dishes to small test tubes and centrifuged at 1,000 rpm for 15 min. The supernate was carefully decanted into counting tubes and counted in duplicate by a three-channel Packard gamma counter (Packard Instrument Co., Inc., LaGrange, Ill.). The mean counts per 5 min released from 1 X 10' Chang cells and standard error of the mean were calculated. Cytotoxicity was measured by 51Cr release into the medium from 5'Cr-labeled Chang liver cells after incubation with peripheral lymphocytes. The percent cytotoxicity was expressed as the mean number of counts released from Chang cells in the presence of lymphocytes, minus spontaneous release of 5'Cr from the Chang cells, divided by the total number of releasable counts, as determined by freeze-thawing the Chang cells.
Study design. Concomitant 72-h incubation studies were performed to assess lymphocyte blastogenesis and T-lymphocyte function as measured by Con A-stimulated incorporation of tritiated thymidine and by cytotoxicity. The importance of serum factors on in vitro lymphocyte function was evaluated in the hepatitis patients by using the following incubation conditions: lymphocytes alone, lymphocytes plus autologous serum, lymphocytes plus HB.Ag-positive homologous serum, lymphocytes plus Con A and autologous serum, and lymphocytes plus purified HB.Ag. Additionally, lymphocytes obtained from acute hepatitis patients were stimulated with Con A in the presence and absence of normal serum to determine the effect of such serum on lymphocyte blastogenesis and cytotoxicity. Finally, the effect of homologous HB.Ag-positive hepatitis serum on normal lymphocyte function (control lymphocytes) was studied in the presence and absence of Con A.
Autologous serum from patients and controls was obtained on the day of study and added to the incubation medium at a concentration of 5%. Homologous HB.Agpositive serum from seven patients with acute hepatitis and two patients with CAH was collected, divided into aliquots, and stored at -70'C. On the day of study, it was thawed ). This preparation had a particle count of 1.6 X 1014/ml, agar gel diffusion titer of 1: 16, nitrogen content of 0.0533 mg/ml, and contained no albumin or gamma globulin by counter electrophoresis or Ouchterlony gel diffusion. Purified HB.Ag was added to the incubation medium undiluted and at 1: 10, 1: 100, and 1: 1,000 dilutions. Statistical analysis. The geometric mean of blast transformation and percent cytotoxicity at 6 and 72 h for experimental and control groups were compared by applying the Student's t test.
RESULTS
Spontaneous lymphocyte cytotoxicity in acute viral hepatitis. Peripheral lymphocytes from patients with acute viral hepatitis were spontaneously cytotoxic to human Chang liver cells when tested at a lymphocyte target cell ratio of 200: 1. Lymphocytes from seven patients and seven normal controls were incubated with target cells for 6 h in this experiment. The mean spontaneous lymphocyte cytotoxicity in patients with acute hepatitis was 12.71±+ 1.06% as compared to 2.71±+ 0.53% (P < 0.001) in normal control individuals (Fig. 1) .
Effect of autologous and homologous HB.Ag-positive serum on spontaneous lymphocyte cytotoxicity in acute viral hepatitis and controls. Spontaneous lymphocyte cytotoxicity -in patients with acute hepatitis is significantly depressed (P < 0.01) when The effect of 5% homologous HB.Ag-positive serum on spontaneous lymphocyte cytotoxicity (72-h incubation) was also studied in seven patients with acute viral hepatitis. In these patients, the mean percent spontaneous lymphocyte cytotoxicity in the absence of human sera was 7.33±1.35, which fell to 3.5±0.96 (P < 0.05) in the presence of homologous serum (Table II) . Autologous normal serum did not inhibit spontaneous lymphocyte cytotoxicity in eight control individuals as shown in Fig. 3 (P < 0.5). There was, however, a significant inhibition of the low level of spontaneous lymphocyte cytotoxicity when normal peripheral lymphocytes were incubated for 72 h in the presence of 5% HBsAg-positive homologous serum. Lymphocyte cytotoxicity fell from 4.41±0.85% to 1.98±0.48% in the (Fig. 4) . There was no difference in lymphocyte cytotoxicity induced by Con A between patients with viral hepatitis and controls. Patients with acute hepatitis had 30.43±5.37% Con A-stimulated cytotoxicity compared to 31.63±5.65% for control (P < 0.5). Similarly, peripheral lymphocytes from patients with CAH and chronic persistent hepatitis were capable of Con Astimulated cytotoxicity (Fig. 4) . The mean percent lymphocyte cytotoxicity in chronic hepatitis was 39.83+ 5.0 compared to 39.16±5.81 in controls.
Effect of autologous and homologous sera on Con Astimulated lymphocyte cytotoxicity. Peripheral lymphocytes from patients with acute viral hepatitis, CAH, and normal controls were incubated with 10 /tg/ml of Con A in the presence of 5% autologous serum to determine if autologous serum also inhibited Con Astimulated cytotoxicity. The results of these experiments are shown in Fig. 5 (Fig. 6) .
Effect of chronic administration of prednisone on Con A-stimulated cytotoxicity. Five patients with CAR who had been taking between 30 and 60 mg of prednisone a day for a mean interval of 2.5 mo were studied. Three of these patients were studied before the administration of prednisone. Chronic administration of prednisone markedly inhibited Con A-stimulated lymphocyte mediated cytotoxicity. As shown in Fig. 7 DISCUSSION Lymphocyte-mediated cytotoxicity is a property of the thymus-dependent or T-lymphocyte population of lymphocytes. Plant lectins, such as PHA, pokeweed mitogen, and Con A, all induce T-lymphocyte blast transformation and these "activated" cells are cytotoxic to target cells in vitro (7) (8) (9) (10) . Similarly, purified protein derivative and other antigens may stimulate blast transformation and cytotoxicity in previously sensitized lymphocytes (11, 12) . In the present study, it was determined that circulating lymphocytes from patients with acute and chronic hepatitis, in the absence of human sera, were spontaneously cytotoxic to human Chang liver target cells. Target cell lysis was most evident in brief 6-h lymphocyte incubation experiments; lower but still significant cytotoxicity was also demonstrated in 72-h incubation studies. The observed difference in spontaneous cytotoxicity at 6 and 72 h probably represents some loss of lymphocyte viability at 72 h since only 80% of these lymphocytes in culture excluded trypan blue. Human serum was replaced by heat-inactivated (56°C for 45 min) fetal calf serum in these experiments. Therefore, the target cells were never exposed to human cytotoxic antibody (13, 14) . This observed spontaneous cytotoxicity in acute viral hepatitis in the absence of human serum suggested in vivo T-lymphocyte activation. There was no difference in Con A-stimulated cytotoxicity between lymphocytes from patients with acute and chronic hepatitis and normal controls in the absence of human sera; implying functionally intact Tlymphocyte populations in both groups. There was a substantial difference between Con A-stimulated cytotoxicity and spontaneous lymphocyte cytotoxicity in this study. This observed difference may be due to the nonspecific stimulation by Con A of a larger lymphocyte population in vitro. Inhibition of PHA-induced lymphocyte blast transformation, when incubated in the absence of autologous sera, has been reported early in the course of acute viral hepatitis (15, 16) . Lymphocyte unresponsiveness was a presumed early direct effect of hepatitis virus on circulating lymphocytes because PHA-induced lymphocyte blast transformation returned to control levels 7-10 days after the onset of jaundice. Most of our patients were studied 7-14 days after the onset of jaundice which may account for a normal T-lymphocyte response to Con A. It is also possible that the method used for lymphocyte separation selected a different lymphocyte population. Furthermore, PHA and Con A may stimulate different subpopulations of lymphocytes (9, 17, 18) .
Autologous and homologous HB.Ag-positive sera have a depressant effect on T-lymphocyte-mediated spontaneous cytotoxicity in acute and chronic hepatitis. The effect is observed in both 6-and 72-h incubation studies. Similarly, autologous HB.Ag-positive sera significantly suppressed Con A-stimulated lymphocyte cytotoxicity in both acute and chronic hepatitis as shown in Fig. 5 . Indeed, homologous HB3Ag-positive serum inhibited Con A-stimulated cytotoxicity in normal control lymphocytes, but autologous normal serum had no such effect. Furthermore, homologous normal serum had no effect on Con A-stimulated lymphocyte cytotoxicity in acute viral hepatitis as shown in Table II . These studies indicate that circulating inhibitory factor(s) are present in sera of patients with acute and chronic hepatitis, which nonspecifically depress cytotoxicity in both hepatitis patients and controls. These inhibitory factor(s) in acute viral hepatitis were found to disappear after recovery.
Homologous sera obtained from patients with acute viral hepatitis, alcoholic hepatitis, primary biliary cirrhosis, asymptomatic HB.Ag antigenemia, halothane hepatitis, and extrahepatic biliary obstruction inhibit PHA-induced proliferation of lymphocytes obtained from healthy individuals (19) (20) (21) (22) (23) (24) . Moreover, normal serum also contains factors that inhibit PHA-stimulated blast transformation and there is evidence that the inhibiting factor in normal serum may be an a, globulin (25) . We found that normal serum depressed spontaneous and Con A-stimulated lymphocyte blast transformation in controls but had no effect on lymphocyte cytotoxicity. However, the identification and characterization of these circulating serum inhibitors of lymphocyte blast transformation in acute and chronic liver disease has not been reported. Our study provides additional evidence that very small amounts (5%) of autologous and homologous HB.Ag-positive sera contain inhibitory factors that not only depress lymphocyte blast transformation but also substantially reduce lymphocyte-mediated cytotoxicity.
T-lymphocyte function as measured by PHA-induced blast transformation and leukocyte migration inhibition has been reported to be abnormal in HB.Ag-positive patients with chronic active and chronic persistent hepatitis (1) (2) (3) . In these studies, however, autologous sera was a component in the assay. Other studies have shown that sera from such patients has an inhibitory effect on PHA-stimulated lymphocyte blast transformation in both patients and normal controls suggesting that lymphocyte function may not be abnormal (26) (27) (28) . Furthermore, PHA and Con A are not exclusively T-lymphocyte mitogens in man since both bone marrowderived (B lymphocytes) and T-lymphocytes blast transform in the presence of these agents (29, 30) . We could detect no difference in Con A-stimulated blast transformation and cytotoxicity between patients with acute and chronic active hepatitis and controls in the absence of autologous serum. Lymphocyte function as measured by in vitro Con A stimulation appears intact in patients with CAH. Indeed, the effect of serum factor(s) on lymphocyte stimulation should be assessed before any conclusions are reached regarding in vitro lymphocyte function.
Homologous HB.Ag-positive serum has been reported to induce blast transformation in lymphocytes from patients recovered from hepatitis B, suggesting prior lymphocyte sensitization by HB.Ag (31, 32) . Purified HB.Ag, when incubated with lymphocytes for 3 and 6 days, failed to stimulate either blast transformation or cytotoxicity in these lymphocytes from our patients who had recovered from hepatitis B and were HB.Ag-negative at the time of study. This preparation of antigen was added to the lymphocyte incubation at four different concentrations. Our study would suggest that factor(s) other than HB.Ag are involved in the stimulation of recovered hepatitic patient lymphocytes.
Corticosteroid therapy has achieved widespread clinical use in diseases where immunologic factors appear to play a role in the pathogenesis (33) . In vitro cellular immune reactions can be broadly divided into an inductive phase, which involves antigen recognition and lymphocyte proliferation, and the effector phase of which lymphocyte-mediated cytolysis is an example (34) . In vitro studies with human lymphocytes suggest that corticosteroids abolish the effector phase of cellmediated immunity and enhances the induction phase (35) . Short-term administration of corticosteroids transiently reduce the absolute number of circulating T lymphocytes. in normal individuals (17, 36) . Corticosteroids also selectively inhibit antigen and lectin induced blast transformation of T-lymphocyte subpopulations (17) . Our in vitro study demonstrates that chronic prednisone therapy in patients with CAH has a marked inhibitory effect on the effector cytolytic phase of cellmediated immunity. In vivo depression of spontaneous lymphocyte cytotoxicity by prednisone offers one explanation for the often observed beneficial effect of corticosteroids on the clinical, biochemical, and histological features of CAH (37) .
